| Trial ID: | L0358 |
| Source ID: | NCT00842205
|
| Associated Drug: |
Heme Oxygenase
|
| Title: |
Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Chronic HCV Infection|Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: pegylated interferon|Drug: Ribavarin
|
| Outcome Measures: |
1. the relation between HO activity and basic virologic and histologic parameters in chronic HCV patients. 2. changes of HO activity within antiviral treatment 3. relation of HO gene polymorphisms to the course of disease|Relation of HO gene polymorphisms and UGT1A1*28 polymorphism.
|
| Sponsor/Collaborators: |
Charles University, Czech Republic|IGA MZ, Czech Republic
|
| Gender: |
All
|
| Age: |
18 Years to 60 Years ?? (Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
150
|
| Study Type: |
Interventional
|
| Study Designs: |
Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science
|
| Start Date: |
January 2007
|
| Completion Date: |
December 2009
|
| Results First Posted: |
--
|
| Last Update Posted: |
February 12, 2009
|
| Locations: |
Cetral Military Hospital, Prague, Czech Republic
|
| URL: |
https://ClinicalTrials.gov/show/NCT00842205
|
